Medical Research Future Fund (MRFF) Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2020
NCT04430192
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Medical Research Future Fund | Medical Research Future Fund (MRFF)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Multiple Trauma (Phase 3)

Prostatic Neoplasms (Phase 2)

Wounds and Injuries (Phase 3)

Wounds, Nonpenetrating (Phase 3)

Wounds, Penetrating (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4